# Advisor Review - Gemini-3-Flash

**Role:** Academic advisor checking for fatal errors
**Model:** gemini-3-flash-preview (ai_studio)
**Paper:** paper.pdf
**Timestamp:** 2026-03-05T16:35:43.412456
**Route:** Direct Google API + PDF
**Paper Hash:** 51b31266daaa05de
**Tokens:** 18838 in / 445 out
**Response SHA256:** fa152a3e917191e3

---

I have reviewed the draft paper "Does Coverage Create Capacity? Section 1115 SUD Waivers and the Supply of Behavioral Health Providers." 

**ADVISOR VERDICT: PASS**

### Review Summary
I have scanned the document for fatal errors in data-design alignment, regression sanity, completeness, and internal consistency. 

1.  **Data-Design Alignment:** The treatment timing (2018–2023) is fully contained within the T-MSIS data coverage window (January 2018–December 2024). The author correctly handles "always-treated" states by excluding those with waivers predating July 2018 to ensure a valid pre-treatment window for the staggered DiD design.
2.  **Regression Sanity:** 
    *   Standard errors in Table 2 and Table 3 are within reasonable ranges for the reported point estimates ($SE < |coefficient| \times 2$ in most cases; no enormous SEs indicating collinearity).
    *   Coefficients for log outcomes (e.g., 0.224, -0.275) are well within the plausible range of $|coefficient| < 10$.
    *   Sample sizes ($N=3,612$) are consistent with the described panel (43 states $\times$ 84 months).
3.  **Completeness:** No placeholder values ("TBD", "XXX") were found. Regression tables include $N$, standard errors, and p-values. Mentioned robustness checks (Stacked DiD, COVID exclusion, state trends) are all reported in Table 3.
4.  **Internal Consistency:** Statistics cited in the abstract and introduction (e.g., CS-DiD ATT of 0.22, p=0.12) match the values presented in Table 2. The adoption timeline in Table 4 aligns with the exclusion criteria for "always-treated" states described in the empirical strategy.

The paper is technically sound and ready for submission to a journal.

**ADVISOR VERDICT: PASS**